SK-LY-16 - Human Cancer - Lymphoma Cell Line

SK-LY-16 - Human Cancer - Lymphoma Cell Line


Species: Human

Category: Cancer

Tissue of Origin: B-cell / Plasma Cell

Cancer Type: Lymphoma - Cancer


SK-LY-16 is a human lymphoma cell line.


This cell line was established from a B-cell in a person with lymphoma

Lead Researcher/Research Laboratory

  • Jorgen Fogh, PhD, formerly at Sloan Kettering Institute, Memorial Sloan Kettering

Key References

Williamson B.D., Carswell E.A., Rubin B.Y., Prendergast J.S., Old L.J. Human tumor necrosis factor produced by human B-cell lines: synergistic cytotoxic interaction with human interferon.Proc. Natl. Acad. Sci. U.S.A. 80:5397-5401(1983) (PubMed ID 6193516)

Licensing Information

This cell line may be licensed nonexclusively for research or commercial purposes.

  • Express License: For internal research purposes by a for-profit entity: Fill out MSK’s Core Express License; see here for links to the online fillable Core Express License, as well as a PDF version. For detailed guidance on how to fill out this webform, see here. Please note:  In order to streamline and expedite the licensing of select MSK cell lines, the terms of this non-exclusive license are non-negotiable. This license is only available for select cell lines, including this one. Once this license has been executed by MSK, you will receive a signed copy and payment instructions; all payments up to $10,000 must be made by credit card.
  • Commercial License: Contact MSK’s Tangible Research Materials team at [email protected].
  • For non-licensing requests from academic-research institutions: Contact MSK’s Antibody & Bioresource Core Facility at [email protected]

Stage of Development

Ready to use